Rohto Pharmaceutical Co.,Ltd. (TYO:4527)

Market Cap	593.83B
Revenue (ttm)	333.80B
Net Income (ttm)	35.74B
Shares Out	225.96M
EPS (ttm)	155.28
PE Ratio	16.92
Forward PE	18.01
Dividend	44.00 (1.67%)
Ex-Dividend Date	Mar 30, 2026

Volume	387,500
Average Volume	575,455
Open	2,652.00
Previous Close	2,631.00
Day's Range	2,618.00 - 2,657.00
52-Week Range	1,964.50 - 2,943.50
Beta	-0.53
RSI	60.30
Earnings Date	Feb 12, 2026

About Rohto Pharmaceutical

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatologi...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1899
• Employees: 9,144
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4527

Financial Performance

In 2024, Rohto Pharmaceutical's revenue was 308.63 billion, an increase of 13.95% compared to the previous year's 270.84 billion. Earnings were 31.01 billion, an increase of 0.23%.